# MAP-IDM: Identification of Molecular Markers of Sudden Death at the Acute Phase of Myocardial Infarction

> **NCT00859300** · — · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 1011 (actual)

## Conditions studied

- Myocardial Infarction

## Interventions

- **GENETIC:** Blood sample
- **GENETIC:** Blood sample

## Key facts

- **NCT ID:** NCT00859300
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 1011 (ACTUAL)
- **Last updated:** 2016-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00859300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00859300, "MAP-IDM: Identification of Molecular Markers of Sudden Death at the Acute Phase of Myocardial Infarction". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00859300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*